Frontiers in Psychiatry | Psychopharmacology

Case Report

Published on 01 Dec 2022

The pathophysiology of rapid fluctuations in mental status associated with olanzapine: A case report

in Psychopharmacology

Tyler J. Torrico

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.1028350

2,950 views
2 citations

Review

Published on 29 Nov 2022

Third-generation antipsychotics in patients with schizophrenia and non-responsivity or intolerance to clozapine regimen: What is the evidence?

in Psychopharmacology

Octavian Vasiliu

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.1069432

25,489 views
20 citations

Original Research

Published on 29 Nov 2022

Reactivations after 5-methoxy-N,N-dimethyltryptamine use in naturalistic settings: An initial exploratory analysis of the phenomenon’s predictors and its emotional valence

in Psychopharmacology

Ana María Ortiz Bernal
Charles L. Raison
Rafael L. Lancelotta
Alan K. Davis

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.1049643

10,427 views
13 citations

Original Research

Published on 17 Nov 2022

A survey of drug liking and cravings in patients using sublingual or intranasal ketamine for treatment resistant depression: A preliminary evaluation of real world addictive potential

in Psychopharmacology

Brittany Chubbs
Jay Wang
Shaina Archer
Carson Chrenek
Atul Khullar
Michael Wolowyk
Jennifer Swainson

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.1016439

4,656 views
10 citations

Original Research

Published on 17 Nov 2022

Sexual dysfunction among people with mental illness attending follow-up treatment at a tertiary hospital, Jimma University Medical Center: A cross-sectional study

in Psychopharmacology

Jerusalem Sewalem
Chalachew Kassaw
Tamrat Anbesaw

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.999922

5,273 views
6 citations

Review

Published on 10 Nov 2022

Biology of cyclooxygenase-2: An application in depression therapeutics

in Psychopharmacology

Ying He
Yuanshan Han
Xiaolin Liao
Manshu Zou
Yuhong Wang

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.1037588

5,248 views
20 citations

Systematic Review

Published on 10 Nov 2022

MDMA for the treatment of misophonia, a proposal

in Psychopharmacology

Jadon Webb
Shannon Keane

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.983285

15,305 views
3 citations

Original Research

Published on 09 Nov 2022

Electroconvulsive therapy for obsessive-compulsive disorder: A retrospective study

in Psychopharmacology

Kun Li
Jiang Long
Wei Deng
Bochao Cheng
Jiaojian Wang

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.1040443

10,226 views
6 citations

Original Research

Published on 09 Nov 2022

Use of central nervous system drugs in combination with selective serotonin reuptake inhibitor treatment: A Bayesian screening study for risk of suicidal behavior

in Psychopharmacology

Tyra Lagerberg
Arvid Sjölander
Robert D. Gibbons
Patrick D. Quinn
Brian M. D’Onofrio
Clara Hellner
Paul Lichtenstein
Seena Fazel
Zheng Chang

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.1012650

2,947 views
1 citation

Case Report

Published on 04 Nov 2022

Acne caused by ziprasidone in a young patient with bipolar disorder: A case report

in Psychopharmacology

Yiwen Yuan
Xiaoqing Li
Xingmei Jiang
Zhixiong Li
Ying Ou
Zhe Li

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.948977

3,621 views
3 citations

Perspective

Published on 03 Nov 2022

Therapeutic setting as an essential component of psychedelic research methodology: Reporting recommendations emerging from clinical trials of 3,4-methylenedioxymethamphetamine for post-traumatic stress disorder

in Psychopharmacology

Lauren Okano
Gregory Jones
Bri Deyo
Alida Brandenburg
Wesley Hale

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.965641

6,354 views
12 citations

Original Research

Published on 03 Nov 2022

MDMA-assisted therapy is associated with a reduction in chronic pain among people with post-traumatic stress disorder

in Psychopharmacology

Devon Christie
Berra Yazar-Klosinski
Ekaterina Nosova
Pam Kryskow
Will Siu
Danielle Lessor
Elena Argento

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.939302

18,180 views
5 citations

Brief Research Report

Published on 26 Oct 2022

Preliminary evidence of links between ayahuasca use and the corpus callosum

in Psychopharmacology

Otto Simonsson
José Carlos Bouso
Florian Kurth
Dráulio B. Araújo
Christian Gaser
Jordi Riba
Eileen Luders

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.1002455

6,510 views
5 citations

Brief Research Report

Published on 26 Oct 2022

Effects of risperidone on psychotic symptoms and cognitive functions in 22q11.2 deletion syndrome: Results from a clinical trial

in Psychopharmacology

Caren Latrèche
Johanna Maeder
Valentina Mancini
Maude Schneider
Stephan Eliez

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.972420

2,047 views
1 citation

Original Research

Published on 21 Oct 2022

Synthetic cannabinoid JWH-073 alters both acute behavior and in vivo/vitro electrophysiological responses in mice

in Psychopharmacology

Mario Barbieri
Micaela Tirri
Sabrine Bilel
Raffaella Arfè
Giorgia Corli
Beatrice Marchetti
Lorenzo Caruso
Marie Soukupova
Virginia Cristofori
Giovanni Serpelloni

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.953909

4,236 views
6 citations

Original Research

Published on 19 Oct 2022

Selective D3 receptor antagonism modulates neural response during negative emotional processing in substance dependence

in Psychopharmacology

Ioanna A. Vamvakopoulou
Leon Fonville
Alexandra Hayes
John McGonigle
Rebecca Elliott
Karen D. Ersche
Remy Flechais
Csaba Orban
Anna Murphy
Dana G. Smith

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.998844

4,116 views
4 citations